Moderna
$192.57Change from previous close: −5.35%Absolute change: −$10.89
Latest news
- FDA approves Moderna's mRNA seasonal flu vaccine (opens in a new tab)
- Moderna to replace Warner Bros Discovery on Nasdaq 100 (opens in a new tab)
- Nasdaq Announces Moderna to Join Nasdaq-100 Index, Replacing Warner Bros. Discovery (opens in a new tab)
- Moderna, Inc. to Join the Nasdaq-100 Index® Beginning October 9, 2026 (opens in a new tab)
- Northwestern's IP License With Feds Doesn't Protect Moderna (opens in a new tab)
- Northwestern Wins Bid to Strike Moderna Government Sales Defense (opens in a new tab)
- Moderna begins Phase 1 clinical trial of Ebola vaccine against strain behind DRC outbreak (opens in a new tab)
- Moderna (MRNA) Stock Dips While Market Gains: Key Facts (opens in a new tab)
- Moderna Stock Is Trending: What's Going On? (opens in a new tab)
- After Moderna's 'Outsized Run,' It May Be Time For This Bearish Move (opens in a new tab)
- Moderna loses US government license defense in Northwestern patent case (opens in a new tab)
- Moderna Climbs 3% Despite Citigroup’s Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water (opens in a new tab)
- Moderna Climbs 3% Despite Citigroup's Downgrade to Sell; BioNTech Inches Higher, Pfizer Treads Water (opens in a new tab)
- Moderna Stock Gets Sell Call As Oncology Hopes Face Valuation Test (opens in a new tab)
- The Escalator: Moderna, Hatteras Venture Partners, PhRMA and more (opens in a new tab)
- Is A Cancer Vaccine Coming? Moderna, Merck Boosted By The Buzz (opens in a new tab)
- Moderna Soars On Cancer Vaccine. Is mRNA Ready For Prime Time? (opens in a new tab)
- Moderna, Merck Rally On Cancer Vaccine Promise. But Is The Multi-Billion-Dollar Hype Real? (opens in a new tab)
- Moderna adds COO role as it expands into oncology (opens in a new tab)
- Moderna, Cerebras, Jabil, HPE, Cal-Maine, Mattel, and More Stocks That Explain Today’s Market (opens in a new tab)
- Why Moderna (MRNA) Shares Are Falling Today (opens in a new tab)
- This Analyst Just Downgraded Moderna Stock. Here's Why. (opens in a new tab)
- Citi Downgrades Moderna Stock, Warning $80 Billion Valuation Asks Too Much of Cancer Pipeline (opens in a new tab)
- After Moderna's Dizzying Rally, It's Time To Sell, Says Analyst (opens in a new tab)
- Moderna Stock Slumps as Citi Says It’s Time to Sell After 500% Rally This Year (opens in a new tab)
- Moderna Shares Reverse Weakness, Rise Over 3% After Key Trading Signal (opens in a new tab)
- Prediction: Moderna Stock Will Soar 100% by 2030 (opens in a new tab)
- Stocks making the biggest moves midday: Rogers, United Therapeutics, Moderna, FormFactor & more (opens in a new tab)
- Moderna vs. BioNTech: Which mRNA Stock Is the Better Buy Now? (opens in a new tab)
- Moderna Tumbles as Citi Advises Selling Following 600% Rally (opens in a new tab)